Endocrine therapy in 2009: consideration of the tumor and the host

Oncology (Williston Park). 2009 Feb;23(2):150-1, 154.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Aromatase Inhibitors / metabolism
  • Aromatase Inhibitors / therapeutic use
  • Biomarkers, Tumor / genetics*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / genetics*
  • Chemotherapy, Adjuvant
  • Female
  • Humans
  • Pharmacogenetics
  • Prognosis
  • Receptor, ErbB-2 / analysis
  • Receptor, ErbB-2 / genetics
  • Receptors, Estrogen / analysis
  • Receptors, Estrogen / genetics*
  • Selective Estrogen Receptor Modulators / metabolism*
  • Selective Estrogen Receptor Modulators / therapeutic use

Substances

  • Antineoplastic Agents, Hormonal
  • Aromatase Inhibitors
  • Biomarkers, Tumor
  • Receptors, Estrogen
  • Selective Estrogen Receptor Modulators
  • Receptor, ErbB-2